Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Assets    
Equity method investments $ 490,297 $ 522,615
Government receivables 514,348 519,485
Commercial receivables 471,077 473,452
Receivables held-for-sale 16,080 19,081
Real estate 340,092 340,824
Investments 151,920 151,209
Cash and cash equivalents 47,150 57,274
Other assets 189,751 166,232
Total Assets 2,220,715 2,250,172
Liabilities:    
Accounts payable, accrued expenses and other 26,528 25,645
Deferred funding obligations 136,505 153,308
Credit facility 69,953 69,922
Non-recourse debt (secured by assets of $1,528 million and $1,545 million, respectively) 1,214,612 1,210,861
Convertible notes 146,165 147,655
Total Liabilities 1,593,763 1,607,391
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 51,826,553 and 51,665,449 shares issued and outstanding, respectively 518 517
Additional paid in capital 770,922 770,983
Accumulated deficit (150,052) (131,251)
Accumulated other comprehensive income (loss) 2,086 (1,065)
Non-controlling interest 3,478 3,597
Total Stockholders’ Equity 626,952 642,781
Total Liabilities and Stockholders’ Equity $ 2,220,715 $ 2,250,172